By BRYAN RAHIJA
In May 2010, leaders at the National Institutes of Health (NIH) proposed a rule that would require NIH-funded researchers to publicly disclose their financial arrangements with drug and medical device companies.
This proposal would bring a much needed dose of transparency to federally funded medical research. Now, one thing stands in its way: the Office of Management and Budget (OMB). POGO is concerned that OMB will weaken or block this proposal, and in July, we sent a letter urging OMB to leave the rule intact.
For this podcast, POGO Staff Scientist Ned Feder and POGO Executive Director Danielle Brian discuss why this proposal is so important. After we recorded this podcast, Nature News reported that the proposal has been dropped. Things aren't completely final just yet—but if the NIH's disclosure proposal does wind up on the cutting room floor, it would be a significant blow to transparency and taxpayer interests. Have a listen to learn more.
- Download the latest podcast
- Subscribe to POGO podcasts via RSS
- Subscribe to POGO podcasts via iTunes
- Previous podcasts
Bryan Rahija edits POGO's blog.
Image by EssG.
Comments